To test whether a thyroxyl-insulin analog with restricted access to receptor sites in peripheral tissues displays relative hepatoselectivity in humans.
Department of Diabetes, Endocrinology and Internal Medicine, Guy's King's and St. Thomas' School of Medicine, King's College London, St. Thomas' Hospital, UK.